Center for Tobacco Products

Deyton, Lawrence

Friday, August 17, 2012: 11:30 AM

2501 ABC (Kansas City Convention Center)

Dr. Lawrence Deyton, MD, MSPH , FDA Center for Tobacco Products

Dr. David Ashley, PhD , US Food and Drug Administration, Center for Tobacco Products, Rockville, MD

Ms. Ann Simoneau, MBA, JD, BS in Pharmacy , Office of Compliance and Enforcement, FDA Center for Tobacco Products, Rockville, MD

Sanjay Koyani, MPH , US Food and Drug Administration, Center for Tobacco Products, Rockville

Learning Objectives

At the conclusion of this presentation attendees will be able to:

List the major themes of the Tobacco Control Act and describe the role of the Center for Tobacco Products (CTP) in tobacco control
Describe CTP's successes to date and be able dialog between state and local tobacco control professionals and FDA
Explain limitations in the tobacco control movement

Cross Cutting Program Area(s): Tobacco Control Policies

Audience: All attendees

Key Points: This session will provide an overview of the Family Smoking Prevention and Tobacco Control Act (TCA); the Food and Drug Administration’s Center for Tobacco Products (CTP); FDA’s public health regulatory framework for tobacco and role in tobacco prevention and control efforts; and important ways for partners to work with FDA.

Educational Experience: Speakers will provide information and updates on CTP’s research priorities to support the TCA; tobacco science for regulatory decision making; current research efforts; compliance and enforcement activities; and public education, authorities and communications.

Benefits: Attendees will learn about FDA’s Action Plan to Combat the Public Health Threat of Tobacco Use and hear from Lawrence Deyton, M.D., M.P.H, Director, Center for Tobacco Products; David Ashley, Ph.D., Ann Simoneau, Director, Office of Science; Ann Simoneau, J.D., MBA, Director, Office of Compliance and Enforcement, and Kathleen Crosby, Director, Office of Health Communications and Education